• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

追踪前列腺活检样本中的类固醇生成,揭示前列腺组织雄激素代谢特征及其潜在的临床应用。

Tracing steroidogenesis in prostate biopsy samples to unveil prostate tissue androgen metabolism characteristics and potential clinical application.

机构信息

State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, 200031, China.

Department of Urology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200065, China.

出版信息

J Steroid Biochem Mol Biol. 2021 Jun;210:105859. doi: 10.1016/j.jsbmb.2021.105859. Epub 2021 Mar 4.

DOI:10.1016/j.jsbmb.2021.105859
PMID:33677016
Abstract

Androgens are essential for prostate cancer development. However, steroidogenesis has mainly been investigated in a limited number of prostate cancer cell lines, leading to varied conclusions and elusive clinical significance. Here, we established an ex vivo research platform with fresh biopsy samples transiently cultured with tritium- labelled androgens to trace steroidogenesis in prostate tissues and investigate its potential clinical application. DHEA was confirmed as the major precursor for androgen synthesis in the prostate. Significant amounts of oxidized DHEA and 5α-androstanedione were generated from DHEA in prostate biopsy samples. Prostatic steroidogenesis was independent of other clinical factors. Furthermore, prostatic steroidogenesis was suppressed after androgen deprivation therapy but increased upon treatment resistance, indicating that prostatic steroidogenesis was affected by clinical treatments. Overall, we provide an accessible research platform to characterize steroidogenesis in prostate tissue and indicate the correlation between prostatic steroidogenesis and disease progression.

摘要

雄激素对于前列腺癌的发展至关重要。然而,类固醇生成主要在少数前列腺癌细胞系中进行了研究,导致了不同的结论和难以捉摸的临床意义。在这里,我们建立了一个离体研究平台,使用氚标记的雄激素对新鲜活检样本进行短暂培养,以追踪前列腺组织中的类固醇生成,并研究其潜在的临床应用。DHEA 被确认为前列腺中雄激素合成的主要前体。在前列腺活检样本中,DHEA 产生了大量氧化的 DHEA 和 5α-雄烷二酮。前列腺类固醇生成与其他临床因素无关。此外,前列腺类固醇生成在去势治疗后受到抑制,但在治疗抵抗时增加,表明前列腺类固醇生成受到临床治疗的影响。总的来说,我们提供了一个易于使用的研究平台来描述前列腺组织中的类固醇生成,并表明前列腺类固醇生成与疾病进展之间的相关性。

相似文献

1
Tracing steroidogenesis in prostate biopsy samples to unveil prostate tissue androgen metabolism characteristics and potential clinical application.追踪前列腺活检样本中的类固醇生成,揭示前列腺组织雄激素代谢特征及其潜在的临床应用。
J Steroid Biochem Mol Biol. 2021 Jun;210:105859. doi: 10.1016/j.jsbmb.2021.105859. Epub 2021 Mar 4.
2
Steroidogenesis in Peripheral and Transition Zones of Human Prostate Cancer Tissue.人前列腺癌组织周边区和移行区的类固醇生成。
Int J Mol Sci. 2021 Jan 6;22(2):487. doi: 10.3390/ijms22020487.
3
The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.雄激素剥夺疗法对前列腺癌患者前列腺组织中二氢睾酮水平的影响。
Clin Cancer Res. 2004 Nov 1;10(21):7121-6. doi: 10.1158/1078-0432.CCR-04-0913.
4
CYP17A1-independent production of the neurosteroid-derived 5α-pregnan-3β,6α-diol-20-one in androgen-responsive prostate cancer cell lines under serum starvation and inhibition by Abiraterone.在血清饥饿条件下,雄激素反应性前列腺癌细胞系中神经甾体衍生的5α-孕烷-3β,6α-二醇-20-酮的CYP17A1非依赖性产生及阿比特龙的抑制作用
J Steroid Biochem Mol Biol. 2017 Nov;174:183-191. doi: 10.1016/j.jsbmb.2017.09.006. Epub 2017 Sep 7.
5
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer.在去势抵抗性前列腺癌进展过程中,雄激素水平通过肿瘤内从头类固醇生成而升高。
Cancer Res. 2008 Aug 1;68(15):6407-15. doi: 10.1158/0008-5472.CAN-07-5997.
6
Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissues.去势单药治疗对癌性前列腺组织中肾上腺雄激素水平的影响。
Steroids. 2011 Feb;76(3):301-8. doi: 10.1016/j.steroids.2010.12.001. Epub 2010 Dec 13.
7
Profiling adrenal 11β-hydroxyandrostenedione metabolites in prostate cancer cells, tissue and plasma: UPC-MS/MS quantification of 11β-hydroxytestosterone, 11keto-testosterone and 11keto-dihydrotestosterone.前列腺癌细胞、组织和血浆中肾上腺11β-羟基雄烯二酮代谢产物的分析:11β-羟基睾酮、11-酮睾酮和11-酮双氢睾酮的超高效液相色谱-串联质谱定量分析
J Steroid Biochem Mol Biol. 2017 Feb;166:54-67. doi: 10.1016/j.jsbmb.2016.06.009. Epub 2016 Jun 21.
8
Reconsideration of progression to CRPC during androgen deprivation therapy.雄激素剥夺治疗期间向去势抵抗性前列腺癌进展的重新考量。
J Steroid Biochem Mol Biol. 2015 Jan;145:164-71. doi: 10.1016/j.jsbmb.2014.03.015. Epub 2014 Apr 6.
9
Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.前列腺癌基质细胞和 LNCaP 细胞通过从脱氢表雄酮合成睾酮和二氢睾酮来共同激活雄激素受体。
Endocr Relat Cancer. 2009 Dec;16(4):1139-55. doi: 10.1677/ERC-09-0070. Epub 2009 Jul 16.
10
Evidence of limited contributions for intratumoral steroidogenesis in prostate cancer.肿瘤内类固醇生成在前列腺癌中作用有限的证据。
Cancer Res. 2010 Feb 1;70(3):1256-64. doi: 10.1158/0008-5472.CAN-09-2092. Epub 2010 Jan 19.

引用本文的文献

1
Androgen Receptor Signalling in Prostate Cancer: Mechanisms of Resistance to Endocrine Therapies.前列腺癌中的雄激素受体信号传导:内分泌治疗耐药机制
Res Rep Urol. 2025 Jun 21;17:211-223. doi: 10.2147/RRU.S388265. eCollection 2025.
2
Active DHEA uptake in the prostate gland correlates with aggressive prostate cancer.在前列腺组织中,DHEA 的摄取与侵袭性前列腺癌呈正相关。
J Clin Invest. 2023 Dec 15;133(24):e171199. doi: 10.1172/JCI171199.
3
Role of single nucleotide polymorphisms of the HSD3B1 gene (rs6203 and rs33937873) in the prediction of prostate cancer risk.
HSD3B1 基因(rs6203 和 rs33937873)单核苷酸多态性在预测前列腺癌风险中的作用。
Mol Med Rep. 2022 Aug;26(2). doi: 10.3892/mmr.2022.12787. Epub 2022 Jul 7.
4
Management of prostate cancer by targeting 3βHSD1 after enzalutamide and abiraterone treatment.在恩杂鲁胺和阿比特龙治疗后通过靶向 3βHSD1 来管理前列腺癌。
Cell Rep Med. 2022 May 17;3(5):100608. doi: 10.1016/j.xcrm.2022.100608. Epub 2022 Apr 20.
5
Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer.抑制 3βHSD1 以消除孕激素在前列腺癌中的致癌作用。
Cell Rep Med. 2022 Mar 15;3(3):100561. doi: 10.1016/j.xcrm.2022.100561.